ML291 is a sufonamidebenzamide compound that induces the unfolded protein response (UPR) and overwhelms the adaptive capacity of UPR, resulting in apoptosis in various solid cancer models. It activates the PERK/eIF2a/CHOP apoptotic pathway of UPR and reduces leukemic cell burden [1].
Molecular Weight:
413.83
Purity:
99.79%
CAS Number:
[1523437-16-2]
Formula:
C16H16ClN3O6S
Target:
Apoptosis|||Others|||PERK
T22104
* VAT and and shipping costs not included. Errors and price changes excepted
